Leading us off today. I think nothing could be better, really. I know were going to hear insights and suggestions and everybodys going to bevery energetic. So please welcome. First of all and i think theyre coming in from the side, doctor jenny columbo, Vice President of global patients and Scientific Affairs at kl pharmaceutical michelle ashman, the director federal advocacy and Alliance Development eli lilly. Doctor gwen nichols, chief medical officer at the leukemia and lymphoma society. Doctor erin oshea, president of the Howard Hughes institute. Doctor peggy amber, foreign secretary of the National Academy of medicineand former commissioner of the fda. And doctor janine clayton, director of the office of research on womens health. Our moderator this morning is doctor loosen the main. The evp and ceo of American Association of colleges pharmacy and im proud to say board member of Research America. Thank you all leaders, we look forward to this. My thanks to the organizers of the fo
So please welcome, first of all, and to think theyre coming in from the side, dr. Jenny colombo, the Vice President global patients and Scientific Affairs at takeda pharmaceuticals. Michele oshman, the director, federal advocacy and Alliance Development at eli lilly. Dr. Gwen nichols, the chief medical officer at the leukemia and lymphoma society. Doctor erin oshea, president of the Howard Hughes medical institute. Doctor peggy hamburg, the foreign secretary of the National Academy of medicine and former commissioner of the fda. And doctor janine clayton, director of the nih office of research on womens health. Our moderator this morning is lucinda maine, ceo of the American Association of colleges of pharmacy, and the pride to say boardmember of research america. Thank you all leaders. We look forward to this. My thanks really to organizers of the forum this year for giving us an opportunity to talk about some things we dont talk about so much, and we have an exemplary panel that brin